DRRIX:NASDAQ
Dreyfus Global Real Return Fund Class I – DRRIX Fund Overview
| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|
| 14.26 | -0.12 (-0.83%) | 13.52 - 14.77 | 0.0 |
Market data as of 6:05PM 06/19/13. Quotes are delayed by at least 15 min.
Overview - DRRIX
The investment seeks total return.
The fund uses an actively-managed multi-asset strategy to produce absolute or real returns with less volatility than major equity markets over a complete market cycle, typically a period of five years. Rather than managing to track a benchmark index, it seeks to provide returns that are largely independent of market moves. The fund allocates its investments among global equities, bonds and cash, and, generally to a lesser extent, other asset classes, including real estate, commodities, currencies and alternative or non-traditional asset classes and strategies. It is non-diversified.
Growth of $10,000 (10 Years)
| Total Return | 5.79% |
|---|
| Yield (Trailing 12 Mo.) | 0.62% |
|---|
| Expense Ratio | 1.35% |
|---|
| Front Load | None |
|---|
| Deferred Load | None |
|---|
| Minimum Investment | $1,000 |
|---|
| Management Tenure | 3 Years |
|---|
| Fund Inception | 05/12/2010 |
|---|
Trailing Total Returns - DRRIX
as of 05/31/2013
| Timeframe | DRRIX | S&P 500 | World Allocation |
|---|
| 1 Month | -0.62% | 2.34% | -1.56% |
|---|
| 3 Month | 3.12% | 8.22% | 1.44% |
|---|
| Year-to-Date | 4.83% | 15.37% | 3.40% |
|---|
| 1 Year | 8.81% | 27.28% | 13.49% |
|---|
| 3 Year | 6.20% | 16.87% | 8.95% |
|---|
| 5 Year | -- | 5.43% | 2.72% |
|---|
| 10 Year | -- | 7.58% | 7.55% |
|---|
| Since Inception | 5.79% | 10.42% | -- |
|---|
Sector Allocation - DRRIX
as of 05/31/2013
| Basic Materials | | 9.83% |
|---|
| Consumer Cyclical | | 2.27% |
|---|
| Financial Services | | 1.79% |
|---|
| Real Estate | | 0.00% |
|---|
| Consumer Defensive | | 14.65% |
|---|
| Healthcare | | 30.32% |
|---|
| Utilities | | 12.05% |
|---|
| Communication Services | | 16.22% |
|---|
| Energy | | 5.03% |
|---|
| Industrials | | 3.81% |
|---|
| Technology | | 4.04% |
|---|
Asset Allocation - DRRIX
as of 05/31/2013
| By Percent | Short | 0% | Long | Net |
|---|
| Stock | 0.00 | | | 15.58 | 15.58 |
|---|
| Bond | 0.00 | | | 14.03 | 14.03 |
|---|
| Other | 0.36 | | | 4.87 | 4.50 |
|---|
| Foreign Stock | 0.00 | | | 42.62 | 42.62 |
|---|
| Foreign Bond | 0.00 | | | 19.16 | 19.16 |
|---|
| Total | 0.36 | | | 96.26 | 95.89 |
|---|
| Cash | 86.85 | | | 90.96 | 4.10 |
|---|
| Total Net Assets | $93.82M |
|---|
| Total Stock Holdings | 41 |
|---|
| Total Bond Holdings | 57 |
|---|
Bond Credit Quality - DRRIX
as of 05/31/2013
| AAA | | 36.64% |
|---|
| AA | | 0.56% |
|---|
| A | | 1.30% |
|---|
| BBB | | 0.27% |
|---|
| BB | | 5.57% |
|---|
| B | | 5.39% |
|---|
| Below B | | 0.00% |
|---|
| Not Rated | | 50.27% |
|---|
Top Ten Holdings - DRRIX
as of 05/31/2013
| Company | YTD Return | % of Assets |
|---|
| US Treasury Bill | -- | 9.37% |
|---|
| DGL | -- | 3.46% |
|---|
| GlaxoSmithKline PLC | 24.67% | 3.35% |
|---|
| Bayer AG | -- | 3.31% |
|---|
| Australia(Cmnwlth) 5.5% | -- | 2.89% |
|---|
| Norway(Kingdom Of) 4.5% | -- | 2.84% |
|---|
| MRK | 19.39% | 2.42% |
|---|
| Novartis AG | 14.18% | 2.34% |
|---|
| RAI | 19.43% | 2.31% |
|---|
| Roche Holding AG | 21.67% | 2.07% |
|---|
Valuation & Growth - DRRIX
as of 05/31/2013
| Valuation | DRRIX | Category Range |
|---|
| Price/Earnings | 6.21 | |
|---|
| Price/Book | 2.39 | |
|---|
| Price/Sales | 1.40 | |
|---|
| Price/Cash Flow | 8.74 | |
|---|
| Dividend Yield | 3.43 | |
|---|
| LT Earnings | 9.03 | |
|---|
| Historical Earnings | 13.78 | |
|---|
| Sales Growth | -1.95 | |
|---|
| Cash-Flow Growth | -2.45 | |
|---|
| Book-Value Growth | -1.42 | |
|---|
